BioSpace News Archive

Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir) with no dose adjustments to treat COVID-19 in people with mild, moderate and severe hepatic impairment.

Arkstone Medical Solutions, a trailblazer in laboratory infectious disease reporting and proactive antimicrobial stewardship, has unveiled its latest innovation—the OneChoice report for microbiology lab results.

CARGO Therapeutics, Inc. (CARGO) today announced the addition of independent directors to the Board of Directors following its recent $200 million Series A financing in March 2023.

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that XDEMVY™ 0.25% is now available at pharmacies nationwide for prescription.

Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc., announced that the Company has contracted with the Ancira Auto Group, a premier auto dealer serving South Texas, to offer EsoGuard® esophageal precancer testing to eligible employees across all twelve of its locations in San Antonio and surrounding areas.

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and biopharma fill-finish machinery.

Bloomage Biotech, a visionary leader in biotechnology and biomaterials, employs an eco-friendly microbial fermentation process to produce hyaluronic acid and other bioactive substances.

Elucida Oncology announced that Ramzi Benamar, a seasoned financial leader with a proven track record in the life sciences industry, has been appointed as Chief Financial Officer, effective September 1, 2023.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.